Max Perutz Labs
Max Perutz Labs is a Vienna-based academic research institute and joint venture of the University of Vienna and the Medical University of Vienna that conducts mechanistic biomedical research across 38 groups, operates a fee-for-service Monoclonal Antibody Facility, and delivers doctoral and postdoctoral training within the Vienna BioCenter.
- Company typePrivate
- Founded2005
- HeadquartersVienna, Austria
- Headcount501–1,000
- GTM typeB2B
- OfferingServices
What Max Perutz Labs does
Max Perutz Labs is an academic research institute, legally organized as Max Perutz Labs Support GmbH, established in 2005 as a joint venture between the University of Vienna and the Medical University of Vienna and embedded within the Vienna BioCenter campus in Vienna, Austria. The institute employs 470 scientists and staff from over 50 nationalities and operates 38 research groups organized into three research areas: Mechanistic Cell and Developmental Biology; Chromatin, RNA and Chromosome Biology; and Structural and Computational Biology. Its mission is to deliver mechanistic understanding of fundamental biomedical processes and link breakthroughs in basic research to advances in human health.
The institute's primary revenue is competitive grant funding from bodies including the Austrian Science Fund (FWF) and the European Research Council (ERC), with 22 ERC grants secured by its scientists. A secondary commercial revenue stream comes from the Monoclonal Antibody Facility (MAF), which has delivered over 130 custom antibody projects for more than 50 customers and produced approximately 200 Western blot-validated monoclonal antibodies since 2009, including the world-wide first CRISPR/Cas9 monoclonal antibody (7A9-3A3), which has been licensed to biotech companies. The institute also runs educational programs — including the Vienna BioCenter PhD Program, the Max Perutz PhD Fellowship (since 2021), the E-STEEM Fellowship, Erasmus exchanges, and postdoctoral training — and provides shared core facilities within the Vienna BioCenter campus.
The institute is governed by Scientific Director Univ.-Prof. Dr. Alwin Köhler. It is a private, non-equity entity, with no traditional funding rounds, M&A, or equity ownership structures; rather, it operates under the joint venture framework of its two founding universities. Service customers and licensing partners are served via a fee-for-service model with tiered (subsidized vs. commercial) pricing for internal versus external academic and non-academic users.
Max Perutz Labs firmographics
Firmographics- Name
- Max Perutz Labs
- Legal name
- Max Perutz Labs Support GmbH
- Website
- https://maxperutzlabs.ac.at
- Company type
- Private
- Founded year
- 2005
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- Max Perutz Labs is a Vienna-based academic research institute and joint venture of the University of Vienna and the Medical University of Vienna that conducts mechanistic biomedical research across 38 groups, operates a fee-for-service Monoclonal Antibody Facility, and delivers doctoral and postdoctoral training within the Vienna BioCenter.
- Ownership category
- akta.pro rank
Max Perutz Labs industry classification
Industry- Product category
- Life Sciences Research
- NAICS
- Medical Laboratories (621511), Colleges, Universities, and Professional Schools (6113), Other Scientific and Technical Consulting Services (541690)
- SIC
- Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Central Laboratory Services (Core Lab Operations) (HLAGAEAA)
- akta.pro secondary industries
- Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays) (HLAAAMAC), Molecular Diagnostics & Genomics Laboratories (HLAFAMAE)
Keywords
Where Max Perutz Labs is headquartered
LocationHeadquarters
- HQ city
- Vienna
- HQ country
- Austria
- HQ region
- Europe
Offices2 records
Markets served
Max Perutz Labs business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales
Revenue model
- Research Funding and Grants: Primary revenue comprises competitive research funding from agencies such as the Austrian Science Fund (FWF), European Research Council (ERC) grants, and other international funding bodies supporting the institute's curiosity-driven research programs.
- Fee-for-Service Scientific Facilities: The Monoclonal Antibody Facility generates revenue by providing custom monoclonal antibody development services to internal researchers, Medical University of Vienna, and external academic and non-academic customers on a fee basis.
- Educational Programs: Revenue from doctoral education programs including the Vienna BioCenter PhD Program, Erasmus exchanges, and specialized training programs for undergraduates and postgraduates.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Internal Users (Max Perutz Labs and Medical University of Vienna) |
| Unit Pricing | Pay-as-you-go | External Academic and Non-Academic Users |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels7 records
Max Perutz Labs product offering
Product offeringCore offering
Max Perutz Labs is a Vienna BioCenter-based molecular biology research institute operating ~38 research groups across three programs (Mechanistic Cell and Developmental Biology; Chromatin, RNA and Chromosome Biology; Structural and Computational Biology). It sells fee-for-service access to scientific Core Facilities, most notably its Monoclonal Antibody Facility (custom monoclonal and polyclonal antibody generation), and delivers graduate and undergraduate training programs in molecular life sciences.
Product overview
Max Perutz Labs is a research institute (not a commercial software company) offering a portfolio of scientific service facilities and educational programs. Its primary product/service is the Monoclonal Antibody Facility (MAF), which provides custom monoclonal antibody development to internal and external academic/non-academic researchers. The institute also operates shared Scientific Facilities within the Vienna BioCenter campus, and delivers education programs including the Max Perutz PhD Fellowship and E-STEEM Fellowship for outstanding researchers. These offerings are interconnected: the Monoclonal Antibody Facility supports research across all labs, the shared facilities provide equipment and services across the campus, and the education programs train the next generation of scientists who staff the labs and utilize the facilities.
Differentiator
Problem solved
Functional benefit
Products and services
- Monoclonal Antibody Facility (MAF) Custom generation and validation of monoclonal and polyclonal antibodies for molecular biology research, offered to internal Vienna BioCenter groups and external academic and commercial clients on a fee-for-service basis.
- Max Perutz Labs Core Facilities Shared Core Facilities spanning monoclonal antibody generation, protein production, cryo-electron microscopy, X-ray crystallography, NMR spectroscopy, mass spectrometry, next-generation sequencing, flow cytometry, confocal and advanced light microscopy, histology, Drosophila and zebrafish facilities, computational biology / HPC and bioinformatic resources, and high-throughput screening.
- PhD and Postdoctoral Training Programs (incl. Vienna BioCenter PhD Program) Structured PhD and postdoctoral training in molecular biology, cell and developmental biology, RNA and chromatin biology, and structural and computational biology, run jointly with the Vienna BioCenter PhD Program partners and the institute's affiliated undergraduate/master's internship training programs.
Quantifiable outcome
- Over 130 monoclonal antibody projects completed for more than 50 customers
- +2 more outcomes
Companies that use Max Perutz Labs
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles2 records
Max Perutz Labs technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability6 records
Feature2 records
Max Perutz Labs partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core and minor.
- University of ViennacoreThe Max Perutz Labs are a joint venture between the University of Vienna and the Medical University of Vienna, established in 2005. The university partnership provides access to academic resources, student pipelines, and institutional support for the institute's research and educational missions.
- Medical University of ViennacoreJoint venture partner alongside the University of Vienna. The proximity to Vienna General Hospital (one of Europe's largest hospitals) creates unique opportunities for translational biomedical research connecting basic science to clinical applications.
- Vienna BioCentercoreThe Max Perutz Labs are embedded in the Vienna BioCenter, one of Europe's premier life sciences hotspots. This provides access to shared outstanding core facilities and creates a vibrant campus community with IMP, IMBA, GMI, and other life sciences institutions.
- Interreg SK-AT (StruBioMol Project)minorThe 3rd StruBioMol Workshop on macromolecular structure determination was funded by the Interreg SK-AT project StruBioMol, supporting cross-border scientific collaboration between Slovakia and Austria.
- IMP (Institute of Molecular Pathology)minorThe Microsymposium on Small RNAs is co-organized by IMP, IMBA, GMI, and Max Perutz Labs. Both institutions share the Vienna BioCenter campus and collaborate on joint seminars and events.
- IMBA (Institute of Molecular Biotechnology)minorCo-organizer of the Microsymposium on Small RNAs and other joint events. IMBA shares the Vienna BioCenter campus with Max Perutz Labs.
- GMI (Gregor Mendel Institute)minorCo-organizer of the Microsymposium on Small RNAs and other joint events. GMI shares the Vienna BioCenter campus with Max Perutz Labs.
- Vienna BioCenter CommunityminorThe Vienna BioCenter community, including VBC PhD Program students and campus institutions, collaborates on symposia, lectures, and shared resources including the Monoclonal Antibody Facility.
Scale indicators8 records
Recent moves8 records
Expansion highlights6 records
Max Perutz Labs competitors and assessment
Company assessmentDirect peers
- MRC Laboratory of Molecular Biology (LMB): Historic UK Medical Research Council institute in Cambridge focused on molecular biology, structural biology, and cell biology. Closely comparable in research focus areas, group-leader structure, and Nobel-laureate heritage (Max Perutz Labs is named after LMB's Max Perutz).
- Whitehead Institute for Biomedical Research: MIT-affiliated US biomedical research institute focused on molecular and cellular biology with a similar group-leader model and university partnership structure. Comparable in research mission and academic-industry translational orientation.
- European Molecular Biology Laboratory (EMBL): Intergovernmental molecular biology research organization with sites across Europe. Comparable in molecular biology research mission, structural biology programs, and serving as a host for visiting researchers and training programs akin to those offered at Max Perutz Labs.
- Friedrich Miescher Institute for Biomedical Research (FMI): Swiss biomedical research institute affiliated with the Novartis Research Foundation. Directly comparable in mission and scale (~300–400 staff), with similar research areas in epigenetics, neurobiology, and quantitative biology, and a similar group-leader driven academic model.
- Institute of Molecular Biology (IMB) Mainz: German research institute focused on quantitative and molecular biology with epigenetics, DNA repair, and gene regulation. Comparable in size, research focus on chromatin/RNA biology, and academic group-leader model.
- The Francis Crick Institute: UK biomedical research institute in London with ~1,500 scientists. Comparable in mission and structure as a large-scale biomedical discovery institute with multiple research programs and core facilities. Larger in absolute scale but serves as a model for the multi-group-leader research institute structure.
- Institute of Molecular Pathology (IMP): Sister research institute co-located on the Vienna BioCenter campus. Directly comparable: ~200 scientists, curiosity-driven biomedical research, Boehringer Ingelheim-funded, and co-organizer of joint events such as the Microsymposium on Small RNAs with Max Perutz Labs.
- Gregor Mendel Institute of Molecular Plant Biology (GMI): Austrian Academy of Sciences molecular biology institute co-located at Vienna BioCenter. Closely comparable operating model: small-to-mid-sized research institute with shared facilities and joint symposia.
- Institute of Molecular Biotechnology (IMBA): Austrian Academy of Sciences institute also located on the Vienna BioCenter campus. Comparable in scope: molecular biology research, ~200 scientists, joint event organization, and shared core facilities with Max Perutz Labs.
Emerging players
- Research Institute of Molecular Pathology (IMP) / AbCellera Biologics: Commercial antibody-discovery platform company. Comparable to the Monoclonal Antibody Facility specifically as an antibody generation service, though operating at much larger commercial scale and serving the broader biotech market.
Market position
Strengths5 records
Weaknesses3 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Max Perutz Labs social profiles
Digital presenceMax Perutz Labs financial estimates
Financial estimateRevenue estimate
Valuation estimate
Max Perutz Labs leadership team
Management profileNumber of profiles
Profiles13 records
Max Perutz Labs funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Max Perutz Labs M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Max Perutz Labs
What does Max Perutz Labs do?
Max Perutz Labs is a Vienna BioCenter-based molecular biology research institute operating ~38 research groups across three programs (Mechanistic Cell and Developmental Biology; Chromatin, RNA and Chromosome Biology; Structural and Computational Biology). It sells fee-for-service access to scientific Core Facilities, most notably its Monoclonal Antibody Facility (custom monoclonal and polyclonal antibody generation), and delivers graduate and undergraduate training programs in molecular life sciences.
Is Max Perutz Labs a public or private company?
Max Perutz Labs is a private company. It is classified as corporate owned and is currently operating.
When was Max Perutz Labs founded?
Max Perutz Labs was founded in 2005. It employs 501 to 1,000 people.
Where is Max Perutz Labs based?
Max Perutz Labs is headquartered in Vienna, Austria, in the Europe region.
How does Max Perutz Labs make money?
Three revenue lines are on record. Research Funding and Grants are the primary driver. The others are fee-for-Service Scientific Facilities and educational Programs.
Who are Max Perutz Labs's main competitors?
Direct peers on record are MRC Laboratory of Molecular Biology (LMB), Whitehead Institute for Biomedical Research, European Molecular Biology Laboratory (EMBL), Friedrich Miescher Institute for Biomedical Research (FMI), Institute of Molecular Biology (IMB) Mainz, The Francis Crick Institute, Institute of Molecular Pathology (IMP), Gregor Mendel Institute of Molecular Plant Biology (GMI) and Institute of Molecular Biotechnology (IMBA). Research Institute of Molecular Pathology (IMP) / AbCellera Biologics is listed as an emerging player.
Does Max Perutz Labs have an API?
No public API is recorded for Max Perutz Labs.
What industry is Max Perutz Labs in?
Max Perutz Labs's product category is Life Sciences Research. Its primary akta.pro industry code is HLAGAEAA, Central Laboratory Services (Core Lab Operations), with a secondary code of HLAAAMAC, Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays). Its NAICS code is 621511 and its SIC code is 8071.